Related Experiment Videos
Marie Starzer1, Helene Gjervig Hansen1, Carsten Hjorthøj1
1Copenhagen Research Centre for Mental Health (CORE), Institut for Klinisk Medicin, Københavns Universitet.
Ugeskrift for Laeger
|September 25, 2024
Summary
Long-term schizophrenia outcomes show limited recovery, with persistent negative symptoms and high mortality indicating an unmet treatment need. Antipsychotics help with psychosis but not negative symptoms, highlighting challenges in schizophrenia management.
Area of Science:
- Psychiatry
- Neuroscience
- Clinical Psychology
Background:
- Schizophrenia is characterized by persistent psychotic and negative symptoms.
- Current treatments, including antipsychotics, offer limited efficacy for negative symptoms.
- Long-term disease trajectories and recovery rates in schizophrenia remain incompletely understood.
Purpose of the Study:
- To review the long-term course of psychotic and negative symptoms in schizophrenia.
- To evaluate the long-term effectiveness of early interventions and antipsychotic treatments.
- To identify unmet needs in schizophrenia management.
Main Methods:
- Systematic literature review of long-term schizophrenia studies.
- Analysis of treatment outcomes for psychotic and negative symptoms.
- Examination of recovery, remission, and mortality rates over 20 years.
Main Results:
- Only 18% of patients achieved clinical recovery after 20 years.
- 40% of patients achieved symptom remission.
- High mortality rates and persistent negative symptoms were observed.
- Early interventions like OPUS showed initial benefits but no lasting disease-modifying effects.
Conclusions:
- Long-term outcomes for schizophrenia remain challenging, with significant unmet needs.
- Negative symptoms and high mortality represent critical areas for future treatment development.
- Current therapeutic strategies require enhancement to address the chronic nature of schizophrenia.